Taiy Chemical
Bradykinin-Like Neuropeptide (Aplysia Californic
Synonym BLN
Species Aplysia californica
Protein Accession Q9XSV2
Purity Greater than 95%
Endotoxin Level Less than 1 EU/ug
Biological Activity Stimulates smooth muscle contraction
Expression System E. coli
Fusion Tag None
Predicted Molecular Mass 2.5 kDa
Formulation Lyophilized powder
Reconstitution Reconstitute in water or buffer solution
Storage & Stability Store at -20°C upon receipt, stable for up to 6 months at -20°C
FAQ
What is Bradykinin-Like Neuropeptide (Aplysia californica)?

Bradykinin-Like Neuropeptide (Aplysia californica) is a compound derived from the central nervous system of the sea slug Aplysia californica. This neuropeptide has garnered significant attention in recent years due to its potential roles in neurological research and possible therapeutic applications. The Aplysia californica, commonly known as the California sea hare, is a marine mollusk traditionally studied for its large, accessible neurons. Scientists are particularly interested in its nervous system because these large neurons offer a straightforward way to navigate the complexities of cellular communication and behaviors in nervous system functions. The Bradykinin-Like Neuropeptide in Aplysia has been found to exhibit properties similar to those of bradykinin in humans, which is a peptide that causes blood vessels to dilate, resulting in lowered blood pressure. In neurological research, bradykinin and its analogs are studied for their roles in pain pathways, inflammation, and cellular communication. The study of Bradykinin-Like Neuropeptide (Aplysia californica) is not only of interest for its physiological effects but also for what its mechanisms can reveal about fundamental biological processes in not just invertebrates but potentially vertebrates as well. Peptides like this one are often used as molecular tools to help uncover the pathways and interactions that underlie various neurological and physiological responses. Researchers hope that these insights can eventually lead to novel treatments or therapies for conditions where these pathways are disrupted or dysfunctional. As with any compound of interest that affects the nervous system, understanding the full range of effects, potential therapeutic windows, and any possible side effects is critical. By continuing to study nature’s biochemical toolkit, researchers are uncovering new perspectives on how neuropeptides can be harnessed for health benefits.

How does Bradykinin-Like Neuropeptide (Aplysia californica) interact with the nervous system?

Bradykinin-Like Neuropeptide (Aplysia californica) interacts with the nervous system by modulating physiological processes that underlie neuromodulation. In the central nervous system of Aplysia californica, these neuropeptides are part of the intricate network that regulates neuronal activity and communication. The interaction with the nervous system begins at the neural receptors where the peptide binds to specific sites, altering the electrical and chemical responses of neurons. The consequence of this modulation is multifaceted. In many instances, Bradykinin-Like Neuropeptides can influence the excitability of neurons, impacting how signals are initiated and propagated. These changes can facilitate or inhibit the release of neurotransmitters, affecting synaptic transmission and plasticity, which are essential for learning and memory. The role of neuropeptides in altering synaptic strength and communication is a fundamental area of interest, as it can shed light on the mechanisms of memory retention and learning, as well as the pathological progression of specific neurological diseases. On a cellular level, the ligand-receptor binding that occurs can activate various intracellular signaling cascades, leading to wide-ranging physiological outcomes. In inflammation, for instance, bradykinin is known to enhance the permeability of blood vessels, promoting the influx of immune cells to the site of injury or infection. In the context of Aplysia, the Bradykinin-Like Neuropeptide is thought to be involved in stress response pathways, which has implications for understanding how organisms respond to environmental and physiological stressors. Moreover, neuropeptides can induce long-term changes in neuron structure and function, such as altering gene expression and metabolic activity, further illustrating their potent and broad regulatory capabilities. Because of these interactions, Bradykinin-Like Neuropeptide (Aplysia californica) is a critical subject in neuropharmacology and biotechnology, offering a window into fundamental neuroscience research and paving the way for new therapeutic strategies.

What potential applications might Bradykinin-Like Neuropeptide (Aplysia californica) have?

Bradykinin-Like Neuropeptide (Aplysia californica) has several potential applications that span across both research and therapeutic realms. One of the most promising applications lies in its utility as a tool for neurological research. Because of the neuropeptide’s role in synaptic modulation and cellular communication, it can be used to study the fundamental processes that govern neuronal responses, synaptic strength, and neuroplasticity. This can help in understanding the mechanisms behind learning, memory, and even neurodegenerative diseases. Exploring such pathways can possibly lead to interventions that ameliorate or potentially reverse the progression of diseases like Alzheimer's, Parkinson's, or other conditions characterized by impaired neuron communication and plasticity. In addition to its research applications, the bradykinin-like properties serve as a basis for investigating new pain management therapies. Bradykinin analogs are often studied for their roles in pain and inflammation pathways, providing a model for designing new analgesics or anti-inflammatory drugs that could offer alternatives to traditional pain management strategies, which can be limited by efficacy issues or side effects like addiction. Furthermore, because bradykinin is involved in the regulation of blood vessel permeability and inflammation, Bradykinin-Like Neuropeptide (Aplysia californica) could have implications in cardiovascular research, particularly in understanding and developing treatments for conditions involving blood pressure regulation and vascular health. Another potential application is in stress physiology, where understanding how organisms respond to and modulate stress at the molecular level can inform therapeutic approaches to stress-related disorders. Finally, this neuropeptide might be employed in synthetic biology and bioengineering. Its known effects could be used to design molecular systems or biosensors that respond to specific biological stimuli, opening up avenues for biotechnological innovation. Each of these applications reflects the broad and varied potential of Bradykinin-Like Neuropeptide (Aplysia californica), showcasing its versatility as both a research tool and potential therapeutic agent in various contexts.

What makes Bradykinin-Like Neuropeptide (Aplysia californica) unique compared to other neuropeptides?

Bradykinin-Like Neuropeptide (Aplysia californica) holds a unique position among neuropeptides due to several distinguishing factors that set it apart in the field of neural research and its potential applications. Firstly, its origin from the central nervous system of Aplysia californica provides researchers with a simplified and accessible model organism known for its exceptionally large neurons, facilitating detailed cellular and molecular studies. This aspect is particularly advantageous for unraveling the complexities of neural processes, offering insights that can be extrapolated to more complex organisms, including humans. Another distinguishing feature is its structural and functional similarity to bradykinin, a well-known peptide in mammalian systems that plays a key role in inflammation, pain modulation, and vascular function. The cross-species examination of this particular neuropeptide offers unique insights into the evolutionary conservation and divergence of neuropeptide functions, allowing researchers to explore ancient biochemical pathways that inform current biological functions and behaviors. Bradykinin-Like Neuropeptide (Aplysia californica) also serves as an important model in studying stress response and adaptation at the neuronal level, offering unique perspectives on how organisms balance external environmental pressures and internal physiological states. As a result, this neuropeptide is invaluable for exploring the underlying genetics and molecular biology of neurophysiological adaptations, providing clues to resilience mechanisms against stressful stimuli, which can have implications for understanding stress-related disorders. Furthermore, its ability to modulate neural pathways with high specificity highlights its potential as a scaffold for designing selective receptor agonists or antagonists, which are fundamentally important in the development of new pharmacological treatments targeting specific neural circuits. This specificity promises fewer side effects and increased efficacy in designing therapeutic agents. Overall, the combination of its unique origin, structural properties, and versatile functionalities differentiates Bradykinin-Like Neuropeptide (Aplysia californica) from other neuropeptides, making it an essential focus for both basic neuroscience research and applied scientific explorations.

How is Bradykinin-Like Neuropeptide (Aplysia californica) studied in a laboratory setting?

Studying Bradykinin-Like Neuropeptide (Aplysia californica) in a laboratory setting involves a variety of sophisticated techniques aimed at unraveling its structure, function, and impact on the nervous system. Researchers begin with isolating and extracting the neuropeptide from the nervous tissue of Aplysia californica. This is typically achieved through methods such as chromatography which enables the purification of specific peptide fractions. Once isolated, structural analysis is conducted using technologies like mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, providing detailed information about the peptide's amino acid composition and three-dimensional conformation. Functional analysis is then carried out, often involving in vitro and in vivo experiments that assess how the neuropeptide influences neuronal activity and behavior. In vitro techniques may include the use of electrophysiological recordings to measure changes in membrane potential or ion currents in response to the application of the neuropeptide. These electrophysiological studies can be conducted in isolated neurons or on neuronal networks cultured in petri dishes, offering a controlled environment to dissect the pathways and mechanisms modulated by the neuropeptide. Complementary to these approaches, genetic and molecular biology tools are employed to understand how the interaction between Bradykinin-Like Neuropeptide and its receptors triggers intracellular signaling cascades. This can involve gene expression analyses using qPCR or RNA sequencing to identify downstream targets and pathways that are differentially regulated following neuropeptide application. Additionally, the use of specific receptor antagonists or gene knockout models can help in establishing causal relationships and elucidating the precise molecular mechanisms at play. Animal models are pivotal in translating these findings to more complex biological systems. Behavioral assays, for instance, are utilized to observe changes in learning, memory, or stress response when the neuropeptide is administered. These studies are often complemented by imaging techniques such as confocal microscopy or fMRI in larger animal models, helping observers visualize changes in the nervous system in real-time. Collectively, these laboratory approaches enable a comprehensive investigation into the multifaceted roles of Bradykinin-Like Neuropeptide (Aplysia californica), paving the way for deeper insights into its potential applications in neuroscience and medicine.

What are the challenges associated with the research of Bradykinin-Like Neuropeptide (Aplysia californica)?

Researching Bradykinin-Like Neuropeptide (Aplysia californica) presents a unique set of challenges that stem from both the biological and technical complexity of working with neuropeptides. One primary challenge lies in the extraction and purification processes. Given that this neuropeptide is derived from the nervous tissue of Aplysia californica, obtaining sufficient quantities for study requires meticulous extraction techniques. Often, advanced chromatography and purification methods must be employed to isolate the neuropeptide without degradation or contamination, which can be labor-intensive and technically demanding. Another challenge is the peptide's intrinsic properties and stability in various experimental conditions. Neuropeptides are prone to rapid degradation in biological environments, which makes their study, particularly in vivo, quite challenging. Ensuring stability requires well-planned experimental protocols and may involve modifying the neuropeptide to resist enzymatic breakdown, which can potentially alter its natural activity. Besides these biological hurdles, there are complexities related to modeling the peptide's interaction in the nervous system. Understanding how Bradykinin-Like Neuropeptide interfaces with its receptors and elicits cellular responses involves dissecting intricate signal transduction pathways. This requires precise biochemical assays and the use of advanced molecular biology techniques, presenting a steep learning curve and requiring significant expertise. Additionally, while Aplysia californica serves as a highly valuable model organism due to its large neurons and relatively simple nervous system, translating findings from this invertebrate model to more complex human systems involves considerable uncertainty. Researchers face challenges in generalizing the outcomes, especially when it comes to applications in human health, which may involve different receptor subtypes and signaling pathways. Finally, funding and resources can also be limiting. Given the specificity of this research, it requires specialized equipment and substantial investment in research teams and laboratory infrastructure. Balancing these needs with available resources necessitates strategic planning and often interdisciplinary collaboration. Despite these challenges, overcoming these obstacles can lead to significant advancements in our understanding of neuropeptides and their potential therapeutic applications, advocating for continued innovation and investment in this area of study.
Leave A Message
Leave A Message ×
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.